US 5,457,182 A · FK-506 cytosolic binding protein, FKBP12.6

Abstract

A new homogeneous cytosolic binding protein (FKBP12.6), having a specific binding activity of about 4.8 mg FK-506 per mg protein and a molecular weight of about 10-12 kilodaltons, reversibly binds the immunosuppressant FK-506, but not cyclosporine A (CSA). The protein is unstable to heating at 56.degree. C. for 30 minutes losing its FK-506 binding affinity. The FKBP12.6 protein is isolated from the cytosol of mammalian tissues, preferably bovine or human brain tissue, and can be used in diagnostic and purification procedures involving FK-506-type macrolide immunosuppressants. The FKBP12.6 protein also has peptidyl-proline isomerase enzymatic activity, catalyzing the cis-trans isomerization of proline-containing peptide bonds. In addition, FKBP12.6 binds to and inhibits the phosphatase calcineurin in the presence of FK-506.

Claims3

Dependent claims

An isolated and purified homogeneous cytosolic binding protein, FKBP12.6, having a specific binding affinity for FK-506 and no specific binding affinity for cyclosporine A, and having a molecular weight in the range of 10-12 kilodaltons, comprising the N-terminal amino acid sequence (SEQ ID NO:1):

Gly Val Glu Ile Glu Thr Ile Ser Pro Gly Asp Gly Arg Thr Phe Pro Lys Lys Gly Gln Thr Cys Val Val His Tyr Thr Gly Met Leu Gln Asn Gly Lys Lys Phe Asp Ser Ser Arg Asp Arg Asn Lys Pro Phe Lys Phe Arg Ile Gly Lys Gln Glu Val Ile Lys Gly Phe Glu Glu Gly Ala Ala Gln Met Ser Leu Gly Gln Arg Ala Lys Leu Thr Cys Thr Pro Asp Val Ala Tyr Gly Ala Thr Gly His Pro Gly Val Ile Pro Pro Asn Ala Thr Leu Ile Phe Asp Val Glu Leu.

Dependencies are inferred from the claim text.

FK-506 cytosolic binding protein, FKBP12.6

Life of this patent

FK-506 cytosolic binding protein, FKBP12.6

Life of this patent

Abstract

Claims3